Organization
Belgian Inflammatory Bowel Disease Research and Development
4 clinical trials
Clinical trial
Subcutaneous Infliximab After A Previous Intravenous Dose OptimizationStatus: Active (not recruiting), Estimated PCD: 2026-05-01
Clinical trial
An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Loss of RESponse to Ustekinumab Treated by Dose EscalationStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASAStatus: Completed, Estimated PCD: 2024-02-01